Share
Market Research Report

PET CANCER THERAPEUTICS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

Segmentation
  • By Therapy TypeChemotherapy · Targeted Therapy · Combination Therapy · and Immunotherapy
  • By Pet TypeCat · Dog · and Horse
  • By Mode of AdministrationOral · Intravenous · and Topical
  • By ApplicationLymphoma · Mast Cell Cancer · Melanoma · Mammary and Squamous Cell Cancer · and Others
  • By GeographyNorth America · Europe · Asia Pacific · Latin America · Middle East · and Africa
  • Published In25 May 2026
  • Report CodeCMI1284
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026 - 2033
  1. Research Objective and Assumption

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Therapy Type
      • Market Snippet, By Pet Type
      • Market Snippet, By Mode of Administration
      • Market Snippet, By Application
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Key Highlights
    • Pipeline Analysis
    • Regulatory Guidelines
    • Initiatives for Prevention of Pet Cancer
    • Approved Targeted Therapies for Pet Cancer
    • Epidemiology
  4. Global Pet Cancer Therapeutics Market, By Therapy Type, 2021-2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022-2033
      • Segment Trends
    • Chemotherapy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Targeted Therapy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Combination Therapy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Immunotherapy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  5. Global Pet Cancer Therapeutics Market, By Pet Type, 2021-2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022-2033
      • Segment Trends
    • Cat
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Dog
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Horse
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  6. Global Pet Cancer Therapeutics Market, By Mode of Administration, 2021-2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022-2033
      • Segment Trends
    • Oral
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Intravenous
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Topical
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  7. Global Pet Cancer Therapeutics Market, By Application, 2021-2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022-2033
      • Segment Trends
    • Lymphoma
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Mast Cell Cancer
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Melanoma
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Mammary and Squamous Cell Cancer
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  8. Global Pet Cancer Therapeutics Market, By Region, 2021-2033, (USD Bn)

    • Introduction
      • Market Share Analysis, By Region, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, For Regions, 2022-2033
    • North America
      • Market Size and Forecast, By Therapy Type, 2021-2033, (USD Bn)
      • Market Size and Forecast, By Pet Type, 2021-2033, (USD Bn)
      • Market Size and Forecast, By Mode of Administration, 2021-2033, (USD Bn)
      • Market Size and Forecast, By Application, 2021-2033, (USD Bn)
      • Market Size and Forecast, By Country, 2021-2033, (USD Bn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Therapy Type, 2021-2033, (USD Bn)
      • Market Size and Forecast, By Pet Type, 2021-2033, (USD Bn)
      • Market Size and Forecast, By Mode of Administration, 2021-2033, (USD Bn)
      • Market Size and Forecast, By Application, 2021-2033, (USD Bn)
      • Market Size and Forecast, By Country, 2021-2033, (USD Bn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Therapy Type, 2021-2033, (USD Bn)
      • Market Size and Forecast, By Pet Type, 2021-2033, (USD Bn)
      • Market Size and Forecast, By Mode of Administration, 2021-2033, (USD Bn)
      • Market Size and Forecast, By Application, 2021-2033, (USD Bn)
      • Market Size and Forecast, By Country, 2021-2033, (USD Bn)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Therapy Type, 2021-2033, (USD Bn)
      • Market Size and Forecast, By Pet Type, 2021-2033, (USD Bn)
      • Market Size and Forecast, By Mode of Administration, 2021-2033, (USD Bn)
      • Market Size and Forecast, By Application, 2021-2033, (USD Bn)
      • Market Size and Forecast, By Country, 2021-2033, (USD Bn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of APAC
    • Middle East
      • Market Size and Forecast, By Therapy Type, 2021-2033, (USD Bn)
      • Market Size and Forecast, By Pet Type, 2021-2033, (USD Bn)
      • Market Size and Forecast, By Mode of Administration, 2021-2033, (USD Bn)
      • Market Size and Forecast, By Application, 2021-2033, (USD Bn)
      • Market Size and Forecast, By Country, 2021-2033, (USD Bn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Therapy Type, 2021-2033, (USD Bn)
      • Market Size and Forecast, By Pet Type, 2021-2033, (USD Bn)
      • Market Size and Forecast, By Mode of Administration, 2021-2033, (USD Bn)
      • Market Size and Forecast, By Application, 2021-2033, (USD Bn)
      • Market Size and Forecast, By Country, 2021-2033, (USD Bn)
        • South Africa
        • Central Africa
        • North Africa
  9. Competitive Landscape

    • Heat Map Analysis
    • Market Share Analysis (3x3 Matrix)
    • Company Profiles
      • Aratana Therapeutics, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • AB Science
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Boehringer Ingelheim International GmbH
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Zenoaq
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Morphogenesis, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • VetDC, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Karyopharm Therapeutics, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Rhizen Pharmaceuticals SA
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Regeneus Ltd.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Oasmia Pharmaceuticals AB
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Zoetis
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
    • Analyst Views
  10. Section

    • References
    • Research Methodology
    • About us and Sales Contact